Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


UK Home Asking Prices Rise for First Time Since May
FAA Allows Boeing to Sell 35 More 777F Freighters Beyond 2028
Yen Weakens as Dollar Gains on Widening US-Japan Rate Gap
Supertanker Orders Surge as US-Iran War Reshapes Oil Trade
US, Japan and South Korea Back Taiwan Ahead of Trump-Xi Summit
Asia Stocks Rise on AI Demand as Oil Eases
Telix to Acquire Germany’s ITM in $1.65 Billion Radiopharma Deal
Japan, U.S. Discuss $19 Billion GlobalFoundries Chip Plant
Fed Rate Hike Threatens Housing as U.S. Growth Leans on AI, Citi Says
U.S. Stock Futures Rise Ahead of Trump-Xi Summit, Middle East Risks Weigh
Apple Pay Set for India Launch With Axis Bank
Strait of Hormuz Oil Shipments Hit Six-Month High as U.S. Clears Mines
Meta Partners With Shopify to Bring Shop Pay Checkout to Muse AI
Westinghouse Targets $50 Billion Valuation in U.S. IPO
Wall Street Mixed as Treasury Yields Rise After Fed Hike
Oil Prices Tumble on U.S.-Iran Diplomacy Hopes, Supply Relief
Paramount-Warner Bros $110 Billion Deal Draws Antitrust Backlash 



